|

Is the UK the new sick man of Europe?

UK growth was actually weaker than expected last quarter, rising by a mere 0.2% on a quarterly basis, down from 0.3%. This drags the annual rate down to 2% from 2.1%. The UK is now beginning to look like the sick man of Europe with strong GDP figures for Q1 from Spain this morning, where GDP rose 0.8% on the quarter and 3% on an annualised basis, overall Eurozone growth expanded by a 0.5% rate over the first three months’ of the year.

Trade weighs down UK growth figure

Weakness in UK growth was mostly centred in trade, exports were downwardly revised to -1.6%, from 0.5% initially, while imports surged by 2.7%. This suggests that the rebalancing away from the consumer is not happening, and the UK’s exporters have not been able to capitalise on the massive 20% devaluation in sterling last year. If the export industry can’t benefit from such a large currency boon, then the sector looks fairly doomed to me.

Some green shoots for business investment

But it wasn’t all bad news. On the bright side, there were some important upward revisions to the GDP report, notably the pick-up in business investment, which jumped by 0.6% in the first quarter after falling 0.9% in the last three months of 2016. Capital spending also rose by 1.2%, which was also revised higher from -0.2% initially. Private consumption was unrevised at 0.3%, and the index of services was revised higher to 0.2% from flat.
This could be a warning sign for Theresa May. If she can’t get a good Brexit deal that protects UK businesses then the UK economy could suffer as other sectors’ of our economy, like exporters and manufacturers, are not strong enough yet to pick up the slack and drive UK growth.

So, is the UK the sick man of Europe? This growth data isn’t encouraging at the early stage of the Brexit negotiations, however, the fact that the US suffered the same fate and is expected to bounce back later this year is also encouraging and the UK data may follow suit. Added to that, UK corporate earnings for Q1 were strong and beat expectations, thus, if the hard data can follow the corporate data higher then we the weakness in the first quarter GDP could be seen as a slip. At this stage it is too early to call the UK the sick man of Europe, however, another quarter of weak numbers could justify this title.

Why this may not derail GBP/USD on its way above 1.30

The market reaction to this report was muted. A second reading of UK GDP doesn’t tend to set the markets alight. The FTSE is mostly flat on the day, there is hesitancy ahead of the Opec meeting later today, and European stocks are not following the US market higher, the S&P 500 made another record close on Wednesday.

The pound is hovering around the 1.30 level, although it backed off highs at 1.3015 ahead of the report. We continue to think that the pound could creep higher, after the market slashed their short bets on the pound for yet another week last week. There could also be further upside after momentum indicators backed away from overbought levels, suggesting that there could be room for further sterling upside from a technical perspective.

Author

Kathleen Brooks

Kathleen has nearly 15 years’ experience working with some of the leading retail trading and investment companies in the City of London.

More from Kathleen Brooks
Share:

Editor's Picks

EUR/USD remains offered below 1.1800, looks at US data

EUR/USD is still trading on the defensive in the latter part of Thursday’s session, while the US Dollar maintains its bid bias as investors now gear up for Friday’s key release of the PCE data, advanced Q4 GDP prints and flash PMIs.
 

GBP/USD bounces off monthly lows near 1.3430

GBP/USD is sliding in tandem with its risk-sensitive peers, drifting back towards the 1.3430 area, its lowest levels in the month. The move reflects a firmer Greenback, supported by another round of solid US data and a somewhat divided FOMC Minutes.

Gold drifts higher to near $5,000 on heightened US-Iran tensions

Gold price holds positive ground near $5,000 during the early Asian session on Friday. The precious metal edges higher as escalating tensions between the United States and Iran boost safe-haven demand. Traders brace for the preliminary reading of US Gross Domestic Product for the fourth quarter, the Personal Consumption Expenditures and the S&P Global Purchasing Managers Index data, which are due later on Friday.

Ethereum: Active addresses halt growth as US selling pressure eases

Ethereum network growth has declined after two months of explosive increase. US selling pressure has eased following an improvement in the Coinbase Premium Index. ETH extends its range-bound move below the $2,107 resistance and above $1,740 .

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.